First Tracks Biotherapeutics, Inc. (NASDAQ:TRAX)

US · Delayed Price · Currency is USD

Healthcare · Biotechnology

Full ChartAlerts Compare

43.48-0.57 (-1.29%)

Market cap

$1.55B

Health Score

64 Sound

Analyst consensus

Buy

Listed since

Apr 20, 2026

Website

firsttracksbio.com

Insider Score

––Not scored

TRAX Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

See stocks that are scored

First Tracks Biotherapeutics, Inc. Executive Compensation

Reading the latest SEC DEF 14A proxy…

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.